RSS
3 Feb 2022

Protalix BioTherapeutics to Participate in the 18th Annual WORLDSymposium™ 2022

Author: admintech | Filed under: Press Release

CARMIEL, Israel, Feb. 3, 2022 /PRNewswire/ — Protalix BioTherapeutics, Inc. (NYSE American: PLX) (TASE: PLX), a biopharmaceutical company focused on the development, production and commercialization of recombinant therapeutic proteins produced by its proprietary ProCellEx® plant…

This entry was posted on Thursday, February 3rd, 2022 at 7:10 am and is filed under Press Release. You can follow any responses to this entry through the RSS 2.0 feed. Both comments and pings are currently closed.

«

»